# AngioDynamics, Inc. (ANGO)

- Sector: Healthcare · Industry: Medical Instruments and Supplies
- SEC CIK: 0001275187 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001275187))
- Full page: https://inspectstocks.com/stocks/ango
- Data as of: price 2026-09-25; newest filing used 2026-07-14; latest fiscal period ended 2026-05-31

## Grade

**B-** on the growth-and-cash rubric, 4 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Revenue growing overall | failed | $320.2M | $338.8M |
| Revenue growing recently | passed | $320.2M | $292.5M |
| Free cash flow positive | passed | $508K |  |
| Free cash flow growing overall | passed | $508K | -$3.7M |
| Free cash flow growing recently | passed | $508K | -$14.6M |

Business quality (the + / − mark): 1 of 6 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | failed | -11.5% |  |
| Healthy profit margin | failed | -11.5% |  |
| Strong operating margin | failed | -12.5% |  |
| Good return on equity | failed | -21.5% |  |
| Debt under control | passed | 0.06 |  |
| Turns sales into cash | failed | 0.2% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $320.2M |
| Net income, trailing twelve months | -$36.7M |
| Free cash flow, trailing twelve months | $508K |
| Net margin | -11.5% |
| Operating margin | -12.5% |
| Return on equity | -21.5% |
| Debt to equity | 0.06 |
| Diluted EPS, trailing twelve months | -$0.87 |
| Share price | $15.49 |
| Market value | $640.2M |
| Price / sales | 2.0x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/ango)
- [Financial statements](https://inspectstocks.com/stocks/ango/financials)
- [Competitors](https://inspectstocks.com/stocks/ango/peers)
- [Earnings](https://inspectstocks.com/stocks/ango/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.